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in a tertiary eye care centerHind M. Alkatan, MD a,⇑; Sultan Al-Zaaidi, MD b; Sreedharan Athmanathan, MD aAbstractMicrosporidia are getting more recognized as causative organism of ocular, gastrointestinal, renal, pulmonary, and sinus diseases,
in both immunocompetent and immunosuppressed patients. Ocular microsporidiosis can be isolated or may present as part of
systemic infection. Recent reports showed increasing number of cases of ocular microsporidiosis in immunocompetent individuals.
The ocular type occurs mainly in two forms: keratoconjunctivitis form which is mostly seen in immunocompromised individuals and
stromal keratitis form seen in immunocompetent individuals. The ocular cases which present with superficial keratitis in acquired
immune deficiency syndrome (AIDS) patients differ from the cases seen in immunocompetent individuals which present mainly as
deep stromal keratitis.
We are presenting the only two documented cases of microsporidial keratitis diagnosed over 25 years of practice in our institution.
The cases are diagnosed by identification of the Acid-fast organisms. Ultrastructure and additional information on species iden-
tification in one of the cases. Both cases are eventually managed by therapeutic PKP. Diagnosis and treatment modalities are dis-
cussed based on a comprehensive literature review.
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Microsporidia are small eukaryotic, spore forming obligate
intracellular parasites, first recognized over 100 years ago.1
The first case of corneal microsporidiosis was published by
Ashton in 1973.2 They are getting more recognized as infec-
tious pathogens causing ocular, sinus, renal, intestinal, pul-
monary, and muscular diseases, in both immunocompetent
and immunosuppressed patients.3,4 Ocular features of this
type of infection can either represent corneal stromal keratitis
which mainly affects immunocompetent patients or superfi-
cial punctuate keratoconjunctivitis which usually affects AIDS
patients or contact lens wearers,4–6 We have encountered
two cases of microsporidial keratitis in our tertiary eye care
center. Both cases are presented with histopathologic and
ultrastructural confirmation of the diagnosis. They were both
managed by therapeutic penetrating keratoplasty (PKP).Peer review under responsibility
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A 42-year-old Saudi male who is a known diabetic pre-
sented to King Khaled Eye Specialist Hospital (KKESH) with
6 months history of right eye redness and pain. He denied
history of trauma or previous similar episodes. Initial ophthal-
mic examination of the right eye revealed visual acuity (VA) of
counting figures at half foot and intraocular pressure (IOP) of
11 mm Hg. He had an epithelial defect with stromal infiltrate
and edema inferiorly. Corneal sensation was intact. The Ante-
rior chamber shower 1+ flare and 1+ cells. His preliminary
diagnosis was herpetic keratitis. The microtrack for herpes
simplex virus (HSV) was negative however, he did respond
to Valcyclovir ‘‘Valtrex’’ 500 mg twice daily and Vigamox
eye drops every 4 h in the right eye. One month later he pre-
sented with painful red right eye with reduced VA to hand
movement and a large corneal abscess measuringj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
uary 2012.
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200 H.M. Alkatan et al.7.5  8.7 mm (Fig. 1(A)). He was started again on the same
medications with no improvement. Therapeutic PKP was per-
formed (9 and 10 mm) combined with Anterior chamber
washout with ceftazidine and vancomycin. Half of the right
eye corneal tissue obtained was sent to microbiology for cul-
ture in addition to Gram, Giemsa, and Calcofluor stains which
showed organisms resembling microsporidia and no fungal
growth. The other half was sent for histopathology which
showed acute stromal keratitis with necrosis and acid fast
organisms resembling spores of Microsporidium (Fig. 1(B)).
Electron microscopy (EM) confirmed the presence of micro-
sporidia (Fig. 1(C) and (D)). The indirect immuno-fluorescence
testing was performed in a referral laboratory facility and was
positive for Encephalitozoon species. The patient did well
after surgery with a clear graft and no evidence of recurrence
and VA of 20/200 (with best corrected vision of 20/40) with a
follow up period of 2 years. Then he developed another at-
tack of right keratitis with negative cultures of the corneal
scraping. The last attack resolved by oral Valtrex 500 mg
twice daily, in addition to topical Vigamox and Predforte
drops. He ended up with a failed graft, however, no further
surgical intervention was performed up to his last follow up
in November 2011.Case 2
A 53-year-old Saudi female who is known to have diabetes
and hypertension. She presented to KKESH with a 3 month
history of pain, redness and reduced vision in her right eye.
Initial evaluation of that eye revealed lid swelling, severe cil-
iary injection, and corneal epithelial defect with an abscess.
No VA was documented in the initial visit. The Anterior cham-
ber findings were not mentioned and the posterior pole was
not visualized at presentation. The patient underwent
therapeutic PKP for her right eye. The half corneal tissue sent
to microbiology for staining showed beaded organisms by
Giemsa stain and the culture was negative for fungal growth.Figure 1. (A) The clinical appearance or the right eye corneal abcess in case
magnification x1000); (C and D) Transmission electron microscopy of microspHistopathology of the remaining corneal tissue revealed
acute stomal keratitis, negative GMS stain and acid fast
organisms consistent with Microsporidium (Fig. 2(A) and
(B)). EM showed several structures resembling microsporidia
(Fig. 2(C)). The patient did well for one year then developed
signs of graft failure with iris adhesions (Fig. 2(D)). Her VA
dropped to HM near the face and was offered a second
PKP which was declined by the patient in her last follow up
in September 2010.Discussion
Ocular microsporidiosis can be isolated or can occur as a
part of systemic infection. Two main forms are recognized:
a form which is mostly seen in immune-compromised individ-
uals and presents as keratoconjunctivitis and the other form
which usually affects immunocompetent individuals and
presents as stromal keratitis.5,6
More cases have been reported in the late 80s7,8 Currey
reported one case of bilateral microsporidial keratitis follow-
ing infection by an insect parasite from the genus Nosema.9
Vemuganti reported a case series of five patients of micros-
poridial stromal keratitis from South India.10 The keratocon-
junctivitis form of the disease has been reported in both
the seronegative HIV patients and healthy individuals.11,12
Currently microsporidia are recognized as an opportunis-
tic infection in the immunocompromised patients. The source
of infection is thought to be either orofaecal, resulting from
direct inoculation, or occurring after trauma.5 Direct inocula-
tion may occur with close contacts representing spread from
other infected persons13,14 or following contact with domes-
tic animals such as cats and birds.9,15
The normal life cycle of microsporidia comprises of
invasion of the spore into the human host cell followed by
discharge of the contents into the cytoplasm .Within the cell
the sporoblast divides by binary fission to form scizont with
2–6 nuclei, which split into unicellular meronts .The meronts1; (B) The appearance of typical microsporidia. (Acid fast stain, original
oridia in the same case (Original magnification x12 K).
Figure 2. (A) Histopathology of the acute stromal keratitis in case 2 (Hematoxylin and eosin, original magnification x100); (B) Similar appearance of
microsporidia organisms within the stroma (Acid fast stain, original magnification x1000); (C) Transmission electron microscopy of structures resembling
microsporida (Original magnification x8000); (D) The clinical appearance of the right eye with a failed corneal graft after 1 year.
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sures about 2.5  1.5 microns. The cell eventually ruptures to
continue the cycle and further destruction of the host
tissue.16
Microbiology facts
In infectious diseases, the isolation techniques and identi-
fication tools provide rapid determination of the causative
organism, the problem with microsporidia is that they are
obligate intracellular parasites requiring cell culture systems
for growth. Therefore, the diagnosis mainly depends on mor-
phological demonstration of the organisms themselves in
scrapings or tissues.
Microsporidia are small (3.5–5.0 lm by 2.0–3.0 lm), oval
obligate intracellular eukaryotic protozoan parasites that be-
long to phylum Microspora. More than 100 species have
been classified into approximately 100 genera, and about
13 species have been reported to infect mammals.4,13–15 Phy-
logenetically microsporidia are early eukaryotic organisms
because they have a true nucleus, possess prokaryotic like
ribosome and lack mitochondria. 14
Joseph reviewed the disease and named four genera that
infect humans Encephalitozoon, Nosema, Pleistophora and
Enterocytozoon.6 Other reports showed that seven genera
(Enterocytozoon species, Brachiola species, Encephalitozoon
species, Pleistophora species, Nosema species, Vittaforma
species and Trachipleistophora species) as well as unclassified
microsporidia (collectively referred to as Microsporidium)
have been associated with human disease involving immuno-
compromised patients.4,13–15
Microsporidia have developed a specific process to infect
their host which takes place in vitro.17 It involves spore
activation and polar tube discharge, by which the infective
sporoplasm is injected into the host cell cytoplasm.18 It is
followed by immediate breakdown of sporoplasm compart-
mentalization, producing an increase in osmotic pressurewhich triggers polar tube eversion and injection of the sporo-
plasm into the host cell.18
Clinical features
Ocular features of this type of infection can either repre-
sent corneal stromal keratitis which mainly affects immuno-
competent patients and is commonly caused by Nosema
corneum4 or superficial punctuate keratoconjunctivitis which
usually affects acquired immune deficiency syndrome (AIDS)
patients or contact lens wearers, in which cases are mostly
caused by genus Encephalitozoon. Keratoconjuctivitis may
also affect immunocompetent humans.
Microsporidial keratitis in healthy persons can mimic her-
petic keratitis with history of recurrent redness, pain, photo-
phobia, watering, and decreased vision. Such cases may be
mistaken and treated with antiviral and topical steroids which
were documented in the management history of our first
case.
The clinical findings include lid edema, congested conjunc-
tiva and corneal lesions. The corneal involvement is usually in
the form of mid to deep stromal infiltrates surrounded by ede-
ma with either intact epithelium and/or epithelial defect over
the stromal lesions. The endothelium does not show
precipitates.
Diagnosis
Microsporidia are small, obligate intracellular parasites that
produce infective spores. They are fastidious organisms that
are difficult to culture. The organism can be isolated using spe-
cial tissue culture techniques, which are available only in few
specialized laboratories, and hence routine microbiological
diagnosis might be difficult.19,20 Alcohol-fixed cytologic sam-
ples of scrapings from the conjunctiva, corneal epithelium, or
both as well as biopsy specimens are proven to be very useful
for demonstrating microsporidial blastospores.8,21
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nosing microsporidiosis. Conjunctival scrapings alone can pro-
vide a satisfactory specimen for cytologic diagnosis in
microsporidial epithelial punctuate keratoconjunctivitis. Cyto-
logic findings demonstrate small, oval organisms within the
epithelial cells, stromal keratocytes, and histiocytes as well
as free extracellular structures.22–24 These spores have uni-
form oval shape and are non-budding, which helps to differen-
tiate them from bacteria and yeasts.25 The spores stain
strongly with gram stain.26,27 Giemsa and 1% acid fast stains
have also been successfully used to demonstrate microspori-
dial spores.22,23 Occasionally, these spores stain poorly or
not at all with routine stains (hematoxylin/eosin or the Papani-
colaou methods), with the organism being easily overlooked
in biopsy specimens or cytologic preparations.25,28
Definitive diagnosis and species differentiation may neces-
sitate EM studies. This has been used for ocular infections by
examination of tissue biopsy from cornea or conjunctiva
using electron microscope to demonstrate the number of
coils of the filament.22–24,26–28To differentiate between Nose-
ma species and Encephalitozoon several electron micro-
scopic features can be identified. In Nosema the coils of
the filament range from 11 to 13 in Nosema versus 4–7 in
Encephalitozoon. The Nosmea are larger than Encephalito-
zoon; also the absence of a parasitophorous vacuole sur-
rounding the organism within the host cell is more
consistent with Nosema.16
Immuno-fluorescent staining techniques are advanced
tools which need specific antibodies only available in re-
search laboratories. This was performed for our first case
for identification of the organism which belongs to Encepha-
litozoon species. In the last few years, the use of molecular
techniques has been developed for the detection and spe-
cies differentiation of microsporidia.Treatment
So far there is no known definitive medical treatment of
deep microsporidial corneal stromal infections.
Some previous reports have suggested that treatment
with topical propamidine isethionate 0.1% (Brolene)28,29or
systemic itraconazole19 which might be effective against
microsporidial superficial keratoconjuctivitis.
Subjective improvement was reported with debulking and
a combination of topical neomycin, polymyxin B and bacitra-
cin antibiotics in a patient with bilateral epithelial keratopathy
caused by Encephalitozoon; while complete resolution was
achieved only after administration of oral itraconazole.22
Successful treatment of microsporidial superficial
keratoconjuctivitis with topical fumagillin has been also re-
ported.30–35 Fumagillin is a naturally secreted water-insoluble
antibiotic of Aspergillus fumigatus and is noted to possess an
inhibitory effect on some intestinal protozoa.34 Fumagillin
bicyclohexylammonium salt is the water soluble form of fum-
agillin used commercially. The mechanism of action of fum-
agillin is not clearly understood but it may alter DNA
content or inhibit RNA synthesis in the organism.36,37 Some
authors have also suggested the role of oral albendazole in
combination with topical fumagillin. Others have shown good
response to medical treatment with systemic albendazole and
topical chlorhexidine in a selected case where the infection is
limited to the mid-stroma.38Secondary infection and penetration of the organisms into
the deeper stroma may follow corneal scrapings, use of top-
ical steroids or bandage contact lenses.23
In case where the medical treatment fails PKP has been
recommended rather than lamellar graft to treat deep stro-
mal microsporidiosis to avoid any chance of recurrence in
the lamellar bed.10 However, deep anterior lamellar keratopl-
asty has been also recently considered as an option for visual
rehabilitation.39Conclusion
Microsporidia are an important cause of disease in both
HIV and non-HIV patients with or without immunosuppres-
sion. High index of suspicion is needed for prompt diagnosis
and treatment. Therefore, ophthalmologists should consider
microsporidia in the differential diagnosis of infectious
keratitis.40
As diagnosis by conventional methods is still challenging
and may need an advanced laboratory tools such as EM, new-
er methods such as molecular biology (PCR) or serology
methods should be developed to be utilized for the diagnosis
and species differentiation of microsporidia which may have
important implication in the management.
Being uncommon or being overlooked again necessitates
careful study of this organism and its microbiological behav-
ior. This also makes the judgment on current therapeutics
incomplete. Many treatment modalities for ocular microspo-
ridiosis have been suggested in the literature including scrap-
ing, bandage contact lenses, steroids, and antimicrobial
agents with successful outcome in selected cases. Fumagillin
has shown to be an effective medical treatment while PKP is
the preferred alternative surgical management.Acknowledgment
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